Robert M. Gervis's most recent trade in Aspen Aerogels Inc. was a trade of 3,178 Stock Option (Right-to-Buy) done . Disclosure was reported to the exchange on June 2, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Aspen Aerogels Inc. | Robert M. Gervis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 3,178 | 3,178 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 2,699 | 355,182 (1%) | 0% | 0 | Common Stock | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Purchase of securities on an exchange or from another person at price $ 33.12 per share. | 22 Mar 2022 | 135,870 | 352,483 (1%) | 0% | 33.1 | 4,500,014 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 26 Nov 2021 | 17,019 | 181,329 (0%) | 0% | 4.2 | 70,629 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2021 | 17,019 | 0 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 26 Nov 2021 | 14,799 | 164,310 (0%) | 0% | 4.7 | 70,295 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2021 | 14,799 | 0 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 26 Nov 2021 | 13,517 | 194,846 (0%) | 0% | 5.3 | 71,235 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2021 | 13,517 | 0 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.08 per share. | 26 Nov 2021 | 11,950 | 206,796 (0%) | 0% | 6.1 | 72,656 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2021 | 11,950 | 0 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.61 per share. | 26 Nov 2021 | 10,228 | 149,511 (0%) | 0% | 6.6 | 67,607 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2021 | 10,228 | 0 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.79 per share. | 26 Nov 2021 | 9,817 | 216,613 (0%) | 0% | 6.8 | 66,657 | Common Stock |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2021 | 9,817 | 0 | - | - | Stock Option (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 3,088 | 3,088 | - | - | Common Stock (Right-to-Buy) | |
Aspen Aerogels Inc. | Robert M. Gervis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,489 | 139,283 (0%) | 0% | 0 | Common Stock |